A new methodology for the characterization of synthetic oligonucleotides has been developed by researchers from the University of Tübingen, Germany.
Photo Credit: stock.adobe.com.nobeastsofierce
A new methodology for the characterization of synthetic oligonucleotides has been developed by researchers from the University of Tübingen, Germany (1).
Synthetic oligonucleotides are a class of synthetic nucleic acids, which are generally 12–30 nucleotides in length. They have gained considerable popularity as a therapeutic tool and are a promising product for the regulation of gene expression. As they are to be used in humans and in clinical trials, their production must lead to high purity products. However, a number of issues can arise during their synthesis, such as deleted or extended base sequences or base modifications, and therefore the purification methods and assays for their quality control must be robust and thorough.
The dominant method currently uses ion-pair reversed-phase chromatography with triethylammonium acetate as an ion-pairing agent because oligonucleotides are poorly retained by common reverse-phase liquid chromatography (LC). However, as this method is hyphenated to mass spectrometry some drawbacks occur, such as ion-suppression in electrospray ionization. As such a methodology with sufficient selectivity and better compatibility for MS detection is desirable.
Towards this end, researchers developed a multiple heart-cutting (MHC) two-dimensional liquid chromatography (2D-LC) method with ultra-violet (UV) and electrospray ionization (ESI) mass spectrometry (MS) detection. The first dimension features a reversed-phase/weak anion-exchange (RP/WAX) stationary phase which provides the selectivity required to separate structurally similar oligonucleotide sequences. The second dimension reversed-phase column desalts via a diverter valve, and the active solvent modulation enables the oligonucleotide peak to be viewed without interference from non-volatile buffer components and ion-pair agents, which allows oligonucleotides to be detected in MS-compatible conditions.
Α α, Β β, Γ γ, Δ δ, Ε ε, Ζ ζ, Η η, Θ θ, Ι ι, Κ κ, Λ λ, Μ μ, Ν ν, Ξ ξ, Ο ο, Π π, Ρ ρ, Σ σ/ς, Τ τ, Υ υ, Φ φ, Χ χ, Ψ ψ, Ω ω
Reference
F. Li et al., J. Chroma. A. 1625, 461338 (2020).
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.